Contacts and Partners

INSTITUTE FOR RESEARCH IN BIOTHERAPY
I.R.B. Director is Professor Bernard KLEIN :
b-klein@chu-montpellier.fr or bernard.klein@inserm.fr

Institut de Recherche en Biothérapie
CHU Montpellier Hôpital Saint-Eloi
80, av. Augustin Fliche.
34295 Montpellier Cedex 5
Phone : (33)4 67 33 01 90
Fax : (33)4 67 33 01 13
e-mail : irb@chu-montpellier.fr

General Secretary
M. Gaétan BERTHAUD
Phone : (33)4 67 33 02 99
g-berthaud@chu-montpellier.fr

Quality Insurance Service
Mme Monique FREI (INSERM), monique.frei@inserm.fr
M. Gaétan BERTHAUD (CHRU), g-berthaud@chu-montpellier.fr

Hospital Secretary
Mme Joelle MEIRARGUES
Phone : (33)4 67 33 01 48
j-meiragues@chu-montpellier.fr

Mme Annie COTTET
Phone : (33)4 67 33 01 00
a-cottet@chu-montpellier.fr

INSERM Unit U1040 - University Secretary
Mme Monique FREI
Phone : (33)4 67 33 04 55
Fax : (33)4 67 33 04 59
monique.frei@inserm.fr

Mme Stéphanie VEZINHET
Phone : (33)4 67 33 04 56
stephanie.vezinhet@inser.fr

IRB Store
Mme Monique SAUNIER
Phone : (33)4 67 33 01 57
monique.saunier@inserm.fr

CHU Montpellier :

Unit for cell and Gene therapy : Dr. John DE VOS
Clinical Investigation Center : Pr. Jean-François ROSSI

Companies installed inside the Institure for Research in Biotherapy :

HORIBA-ABX SAS Company
BETA-INNOV Company

Montpellier Partners :

IGMM
IGH
IGF

National Partners :

French Blood Center (EFS) : EFS is one of the major French and European Biotherapy institutes. IRB needs to develop strong collaborations with EFS in order to reinforce us mutually. This cooperation was already very fruitful for computerization of quality insurance procedures in cell therapy. This will be one of my major objectives in the next 2 years.>> See website.
Orpheme : Orpheme is a new pole for emerging pathologies and orphan disease.>>See website.

Competitivity pole.

French government has created 68 competitivity poles which aim is to gather academic research and companies in order to create new activities and employment. Regenerative medicine was recognized as one of the fourth priority of our region in the field of biology and we are integrated in the Orpheme competitivity pole that is driven by Sanofi-Aventis, a large world pharmaceutical company.

Canceropole Grand Sud Ouest.

Regarding cancer research, we are linked with Toulouse, Bordeaux and Limoges through the canceropole Grand Sud Ouest supported by the French Cancer Institute. Prof. B. klein is one of the three responsibles of the biotherapy field of this canceropole. >> See website

Link with associations.

IRB is supported by the French association against Myopathy. >> See website
IRB teams is also supported by various associations, in particular the French League against Cancer. >> See website

European Network :

Besides the funding of the team projects through European FP7 grants, IRB will be included into a network of European institutes in order to promote a European force in the field of regenerative medicine. In particular, we will create a European school in regenerative medicine.